feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

CTET application closing December 18

trending

Tata Sierra bookings open

trending

Sydney Sixers vs Strikers

trending

ICICI Prudential IPO allotment soon

trending

India South Africa T20 abandoned

trending

PSG vs Flamengo lineups

trending

Osasuna edges Huesca 2-1

trending

Chakravarthy leads ICC T20I rankings

trending

Ikkis release date delayed

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / NHS Faces Flu Treatment Crisis: No Proven Cures

NHS Faces Flu Treatment Crisis: No Proven Cures

17 Dec

•

Summary

  • No proven treatments exist for severe flu patients in NHS hospitals.
  • A new 'superflu' strain, H3N2, is causing a dangerous early surge.
  • Flu vaccines are less effective for the elderly against this strain.
NHS Faces Flu Treatment Crisis: No Proven Cures

The National Health Service (NHS) is grappling with a severe lack of proven treatments for flu patients admitted to hospitals. Professor Sir Peter Horby, who previously identified a COVID-19 treatment, is now leading trials to find effective flu therapies.

The current surge is fueled by a new H3N2 strain, referred to as 'superflu,' which poses a greater risk to older individuals. Despite a record number of flu hospitalisations, existing treatments like Tamiflu lack robust evidence for severe cases, unlike treatments developed for COVID-19.

Vaccine effectiveness against the H3N2 strain is notably lower in individuals over 65, with protection rates significantly reduced compared to younger age groups. Experts are investigating if this new strain and waning immunity post-pandemic are contributing factors to the early and intense flu season.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Currently, there are no treatments proven to be effective for patients hospitalised with severe influenza within the NHS.
The H3N2 strain is causing an early and significant surge in flu cases, and it appears to be more dangerous, particularly for older people.
While vaccines remain the best protection, their effectiveness is significantly reduced in the elderly, offering only 32% protection against the new strain.

Read more news on

Healthside-arrow

You may also like

UK Flu Alert: Tidal Wave of Infections Looms

13 Dec • 38 reads

article image

NHS Flu Crisis: Hospitals Overwhelmed

12 Dec • 51 reads

article image

Flu Jab: Buy Now or Wait?

9 Dec • 69 reads

article image

Scotland's NHS Overwhelmed by Worst Flu Crisis

5 Dec • 94 reads

article image

NHS Warns: Sleep Position May Worsen Covid Cough

22 Nov • 119 reads

article image